Lexaria Bioscience Corp.

NASDAQ: LEXX · Real-Time Price · USD
0.86
-0.01 (-1.61%)
At close: Jun 26, 2025, 3:59 PM
0.89
3.35%
After-hours: Jun 26, 2025, 06:30 PM EDT
-1.61%
Bid 0.8
Market Cap 16.75M
Revenue (ttm) 525.92K
Net Income (ttm) -9.38M
EPS (ttm) -0.61
PE Ratio (ttm) -1.41
Forward PE -1.59
Analyst Buy
Ask 0.95
Volume 168,657
Avg. Volume (20D) 106,485
Open 0.83
Previous Close 0.87
Day's Range 0.83 - 0.93
52-Week Range 0.83 - 4.38
Beta 0.94

About LEXX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LEXX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LEXX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 months ago
-20.12%
Lexaria Bioscience shares are trading lower. The c... Unlock content with Pro Subscription
5 months ago
-6.31%
Lexaria Bioscience shares are trading lower. The company announced partial final results showcasing the tolerability and glycemic control efficacy findings from human study GLP-1-H24-3.